The Framingham, Mass.-based device maker's non-surgical intravesical system gets the OK to hit the market in the European Union.
Solace Therapeutics Inc. won CE Mark approval in the European Union for its intravesical system to treat female stress urinary incontinence.
The Framingham, Mass.-based medical device maker said its device is a small, quarter-sized balloon that floats inside the bladder. Inserted via catheter during an out-patient procedure, the balloon is designed to relieve the pressure fluctuations within the bladder that lead to incontinence.
Holliston, Mass.-based scientific instrument maker Harvard Bioscience launches a bioreactor as it...
Portsmouth, N.H.-based IV infusion system developer Fluidnet Corp. drums up $9 million in an equity...
The Food & Drug Administration and Health Canada both cleared a Polish reactor to supply Covidien...
The U.S. Attorney for Massachusetts issues a "civil investigative demand" for documents on...
Boston Scientific Corp. wins Food & Drug Administration clearance for its Express LD Iliac stent...